Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
fda
archive
medical
clinical trials
life sciences
national blog main
boston
boston blog main
medicine
abbvie
aldehyde
aldeyra therapeutics
allergan
allergic conjunctivitis
andrew berens
avapritinib
big pharma
biotech
blueprint medicines
boehringer ingelheim
boston top stories
cancer
coronavirus
deciphera pharmaceuticals
drugs
dry eye disease
eli lilly
empagliflozin
europe
europe blog main
europe top stories
extreme
eye drops
gastrointestinal stromal tumor
gist
gleevec
imatinib
indiana blog main
indiana top stories
new york blog main
What
fda
9
×
type
9
×
drug
cancer
new
approval
approves
announced
blood
called
diabetes
eye
filing
impurity
medicine
recalled
risk
short
treats
used
acute
administration
aldeyra
batch
battelle
benefit
bid
blueprint
boehringer
brand
cause
caused
causing
chasing
closer
commonly
contracting
coronavirus
countries
critically
Language
unset
Current search:
type
×
fda
×
@extremetech.com
2 years ago
FDA Approves New Eye Drops that Could Replace Glasses for Millions
@slashgear.com
3 years ago
Popular diabetes drug recalled months after FDA issued cancer risk warning
@slashgear.com
3 years ago
Another batch of metformin recalled over cancer-causing impurity
@slashgear.com
4 years ago
FDA approves Battelle tech for decontaminating N95 respirators
@xconomy.com
4 years ago
FDA Rejects Boehringer Ingelheim, Eli Lilly Drug for Type 1 Diabetes
@slashgear.com
4 years ago
FDA approves new drug that immediately treats migraines
@xconomy.com
4 years ago
Chasing Blueprint, Deciphera Plans FDA Filing for GI Cancer Drug
@slashgear.com
4 years ago
The FDA just fast-tracked this new blood cancer treatment
@xconomy.com
5 years ago
New Data Puts Aldeyra One Step Closer to FDA Filing for Eye Drug